We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tate & Lyle Plc | LSE:TATE | London | Ordinary Share | GB00BP92CJ43 | ORD 29 1/6P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 648.50 | 648.00 | 649.00 | 652.00 | 640.00 | 645.50 | 386,185 | 15:26:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Flavoring Extract,syrup, Nec | 1.65B | 188M | 0.4180 | 15.56 | 2.92B |
Date | Subject | Author | Discuss |
---|---|---|---|
14/9/2021 14:48 | Bought a few SN spoole fwiw, not high conviction though. Added a few TATE. | essentialinvestor | |
14/9/2021 14:25 | May as well back the stock now with the proceeds at this price | spoole5 | |
14/9/2021 13:49 | Major institutional holders can stop the deal passing if they wish. If they were unhappy, guessing there would have been reports of this by now. | essentialinvestor | |
14/9/2021 13:43 | The market is indicating otherwise | spoole5 | |
14/9/2021 10:51 | Have to take a good deal on trust that the CEO and BOD are calling this transaction correctly, let's hope so. | essentialinvestor | |
14/9/2021 10:42 | GM and voting to held on 30th Sept. I suspect the deal will easily be accepted. | cfro | |
14/9/2021 09:31 | We all know what happens to businesses that are sold to financial operators - redundacies. So director selling shares not a bad idea - especially if you’re not offered some great pre-“rationali | yump | |
14/9/2021 09:11 | Struggling to hold 700. | spoole5 | |
12/9/2021 10:30 | Anyone know the timeline for approval of the bid ? | tornado12 | |
11/9/2021 15:47 | Added a small amount yesterday, did not get the brief dip below £7 unfortunately. | essentialinvestor | |
31/8/2021 13:01 | Didn't think it would be today! | spoole5 | |
31/8/2021 07:52 | Will my 7 target be hit this week | spoole5 | |
27/8/2021 12:09 | We dont really know the true reason as to why that director has sold so many shares. It might be because he is about to lose his job perhaps as president of the primary products division. | cfro | |
27/8/2021 09:27 | Should be clearer at the next trading update. End of the day a director has recently sold the best part of £1 million worth of his personal holding in TATE. | essentialinvestor | |
26/8/2021 10:52 | Well it looks like it's being priced in. If the deal goes ahead i think a buyback is much more attractive with shares at current levels | spoole5 | |
26/8/2021 10:40 | spoole, wonder if we are looking at an FY guidance cut here?. Increasing costs may be hitting the bottom line, I can see the same for Unilever. Having held TATE many times over the years, it has frequently traded in a very approx £6.30 - £6.00 type of range. | essentialinvestor | |
26/8/2021 07:28 | Yep, was slated for predicting that. Deal has most certainly gone quiet | spoole5 | |
25/8/2021 14:07 | Had a small amount. | essentialinvestor | |
25/8/2021 14:00 | spoole, getting near your Under £7 call. | essentialinvestor | |
23/8/2021 16:01 | It could possibly be inflationary costs impacting margins in the primary products division? - just speculating here. | essentialinvestor | |
23/8/2021 15:47 | Surely heading to level that might flush out a full bid now. | spoole5 | |
23/8/2021 15:33 | spoole, might wonder why a sale of that magnitude by the divisional head?. | essentialinvestor | |
23/8/2021 14:52 | My 700 target should be reached soon. Surely this dud deal will be dead in the water soon | spoole5 | |
20/8/2021 15:41 | A very chunky share sale. | essentialinvestor | |
18/8/2021 14:53 | Jim Stutelberg sold 110k shares. He is president of the Primary products division. Perhaps he see's his job vanishing if the deal goes through? | cfro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions